[1] Kubowicz, P., Zelaszczyk, D. and Pekala, E. (2013) RNAi in Clinical Studies. Current Medicinal Chemistry, 20, 1801-1816.
http://dx.doi.org/10.2174/09298673113209990118
[2] Zhang, S.B., Zhi, D.F. and Huang, L. (2012) Lipid-Based Vectors for siRNA Delivery. Journal of Drug Targeting, 20, 724-735.
http://dx.doi.org/10.3109/1061186X.2012.719232
[3] Zhou, J.H., Shum, K.T., Burnett, J.C. and Rossi, J.J. (2013) Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges. Pharmaceuticals, 6, 85-107.
http://dx.doi.org/10.3390/ph6010085
[4] de Fougerolles, A.R. (2008) Delivery Vehicles for Small Interfering RNA in Vivo. Human Gene Therapy, 19, 125-132.
http://dx.doi.org/10.1089/hum.2008.928
[5] Eliyahu, H., Servel, N., Domb, A.J. and Barenholz, Y. (2002) Lipoplex-Induced Hemagglutination: Potential Involvement in Intravenous Gene Delivery. Gene Therapy, 9, 850-858.
[6] Simberg, D., Weisman, S., Talmon, Y., Faerman, A., Shoshani, T. and Barenholz, Y. (2003) The Role of Organ Vascularization and Lipoplex-Serum Initial Contact in Intravenous Murine Lipofection. The Journal of Biological Chemistry, 278, 39858-39865.
http://dx.doi.org/10.1074/jbc.M302232200
[7] Hattori, Y., Nakamura, A., Arai, S., Nishigaki, M., Ohkura, H., Kawano, K., Maitani, Y. and Yonemochi, E. (2014) In Vivo siRNA Delivery System for Targeting to the Liver by Poly-L-Glutamic Acid-Coated Lipoplex. Results in Pharma Sciences, 4, 1-7.
http://dx.doi.org/10.1016/j.rinphs.2014.01.001
[8] Hattori, Y., Arai, S., Okamoto, R., Hamada, M., Kawano, K. and Yonemochi, E. (2014) Sequential Intravenous Injection of Anionic Polymer and Cationic Lipoplex of siRNA Could Effectively Deliver siRNA to the Liver. International Journal of Pharmaceutics, 476, 289-298.
http://dx.doi.org/10.1016/j.ijpharm.2014.09.059
[9] Song, Y.K., Liu, F., Chu, S.Y. and Liu, D.X. (1997) Characterization of Cationic Liposome-Mediated Gene Transfer in Vivo by Intravenous Administration. Human Gene Therapy, 8, 1585-1594.
http://dx.doi.org/10.1089/hum.1997.8.13-1585
[10] Templeton, N.S., Lasic, D.D., Frederik, P.M., Strey, H.H., Roberts, D.D. and Pavlakis, G.N. (1997) Improved DNA: Liposome Complexes for Increased Systemic Delivery and Gene Expression. Nature Biotechnology, 15, 647-652.
http://dx.doi.org/10.1038/nbt0797-647
[11] Lu, C., Stewart, D.J., Lee, J.J., Ji, L., Ramesh, R., Jayachandran, G., Nunez, M.I., Wistuba, I.I., Erasmus, J.J., Hicks, M.E., Grimm, E.A., Reuben, J.M., Baladandayuthapani, V., Templeton, N.S., McMannis, J.D. and Roth, J.A. (2012) Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans. PloS ONE, 7, e34833.
http://dx.doi.org/10.1371/journal.pone.0034833
[12] Tan, Y., Liu, F., Li, Z., Li, S. and Huang, L. (2001) Sequential Injection of Cationic Liposome and Plasmid DNA Effectively Transfects the Lung with Minimal Inflammatory Toxicity. Molecular Therapy, 3, 673-682.
http://dx.doi.org/10.1006/mthe.2001.0311
[13] Tagami, T., Suzuki, T., Matsunaga, M., Nakamura, K., Moriyoshi, N., Ishida, T. and Kiwada, H. (2012) Anti-Angiogenic Therapy via Cationic Liposome-Mediated Systemic siRNA Delivery. International Journal of Pharmaceutics, 422, 280-289.
http://dx.doi.org/10.1016/j.ijpharm.2011.10.059
[14] Wollenberg, B., Kastenbauer, H.M., Schaumberg, J., Mayer, A., Andratschke, M., Lang, S., Pauli, C., Zeidler, R., Ihrler, S., Lohrs, K.N. and Rollston, R. (1999) Gene Therapy—Phase I Trial for Primary Untreated Head and Neck Squamous Cell Cancer (HNSCC) UICC Stage II-IV with a Single Intratumoral Injection of hIL-2 Plasmids Formulated in DOTMA/Chol. Human Gene Therapy, 10, 141-147.
http://dx.doi.org/10.1089/10430349950019273
[15] Jin, Y., Wang, S., Tong, L. and Du, L. (2015) Rational Design of Didodecyldimethylammonium Bromide-Based Nano-assemblies for Gene Delivery. Colloids and Surfaces B: Biointerfaces, 126, 257-264.
http://dx.doi.org/10.1016/j.colsurfb.2014.12.032
[16] Kurosaki, T., Kitahara, T., Fumoto, S., Nishida, K., Yamamoto, K., Nakagawa, H., Kodama, Y., Higuchi, N., Nakamura, T. and Sasaki, H. (2010) Chondroitin Sulfate Capsule System for Efficient and Secure Gene Delivery. Journal of Pharmacy & Pharmaceutical Sciences, 13, 351-361.
[17] Kurosaki, T., Kitahara, T., Kawakami, S., Higuchi, Y., Yamaguchi, A., Nakagawa, H., Kodama, Y., Hamamoto, T., Hashida, M. and Sasaki, H. (2010) Gamma-Polyglutamic Acid-Coated Vectors for Effective and Safe Gene Therapy. Journal of Controlled Release, 142, 404-410.
http://dx.doi.org/10.1016/j.jconrel.2009.11.010
[18] Moghimi, S.M. and Hunter, A.C. (2001) Recognition by Macrophages and Liver Cells of Opsonized Phospholipid Vesicles and Phospholipid Headgroups. Pharmaceutical Research, 18, 1-8.
http://dx.doi.org/10.1023/A:1011054123304
[19] Hattori, Y., Yamashita, J., Sakaida, C., Kawano, K. and Yonemochi, E. (2015) Evaluation of Antitumor Effect of Zoledronic Acid Entrapped in Folate-Linked Liposome for Targeting to Tumor-Associated Macrophages. Journal of Liposome Research, in Press.
[20] Lorenz, C., Hadwiger, P., John, M., Vornlocher, H.P. and Unverzagt, C. (2004) Steroid and Lipid Conjugates of siRNAs to Enhance Cellular Uptake and Gene Silencing in Liver Cells. Bioorganic & Medicinal Chemistry Letters, 14, 4975-4977.
http://dx.doi.org/10.1016/j.bmcl.2004.07.018
[21] Nair, J.K., Willoughby, J.L., Chan, A., Charisse, K., Alam, M.R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A.V., Milstein, S., Taneja, N., O’Shea, J., Shaikh, S., Zhang, L., van der Sluis, R.J., Jung, M.E., Akinc, A., Hutabarat, R., Kuchimanchi, S., Fitzgerald, K., Zimmermann, T., van Berkel, T.J., Maier, M.A., Rajeev, K.G. and Manoharan, M. (2014) Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing. Journal of the American Chemical Society, 136, 16958-16961.
http://dx.doi.org/10.1021/ja505986a